Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology
The subjectivity of morphological assessment and the overlapping pathological features of different subtypes of myeloproliferative neoplasms (MPNs) make accurate diagnosis challenging. To improve the pathological assessment of MPNs, we developed a diagnosis model (fusion model) based on the combination of bone marrow whole-slide images (deep learning [DL] model) and clinical parameters (clinical model). Thousand and fifty-one MPN and non-MPN patients were divided into the training, internal testing and one internal and two external validation cohorts (the combined validation cohort). In the combined validation cohort, fusion model achieved higher areas under curve (AUCs) than clinical or DL model or both for MPNs and subtype identification. Compared with haematopathologists with different experience, clinical model achieved AUC which was comparable to seniors and higher than juniors (p = 0.0208) for polycythaemia vera. The AUCs of fusion model were comparable to seniors and higher than juniors for essential thrombocytosis (p = 0.0141), prefibrotic primary myelofibrosis (p = 0.0085) and overt primary myelofibrosis (p = 0.0330) identification. In conclusion, the performances of our proposed models are equivalent to senior haematopathologists and better than juniors, providing a new perspective on the utilization of DL algorithms in MPN morphological assessment.
Authors
- Qian Wang (ORCID: https://orcid.org/0000-0003-0900-2806)
- Lei Fan (ORCID: https://orcid.org/0000-0002-9368-4987)
- Liangmin Wei
- Minghui Duan (ORCID: https://orcid.org/0000-0003-2130-6300)
- Guanyu Yang (ORCID: https://orcid.org/0000-0003-3704-1722)
- Jinhong Mei (ORCID: https://orcid.org/0000-0002-7082-3139)
- Min Xiao (ORCID: https://orcid.org/0000-0001-9421-6344)
- Jianyao Huang (ORCID: https://orcid.org/0000-0003-4177-6393)
- Yongyue Wei (ORCID: https://orcid.org/0000-0002-1132-1796)
- Rong Wang (ORCID: https://orcid.org/0000-0002-2169-4174)
- Feng Chen (ORCID: https://orcid.org/0000-0002-2699-7190)
- Yuan Zhang (ORCID: https://orcid.org/0000-0003-3770-0046)
- Jianyong Li (ORCID: https://orcid.org/0000-0002-9931-4055)
- Xiaomei Hu
- Wenyi Shen (ORCID: https://orcid.org/0000-0001-8673-0407)
- Jieyu He (ORCID: https://orcid.org/0000-0003-1552-7780)
- Suning Chen (ORCID: https://orcid.org/0000-0002-2967-3597)
- Zhongxun Shi (ORCID: https://orcid.org/0000-0003-4000-8210)
- Jin Wang (ORCID: https://orcid.org/0009-0002-4560-8231)
Institutions
- Fujian Medical University (CN)
- Nanjing University of Chinese Medicine (CN)
- Nanchang University (CN)
- Anhui Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Peking Union Medical College Hospital (CN)
- Soochow University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Tongji Hospital (CN)
- Union Hospital (CN)
- First Affiliated Hospital of Nanchang University (CN)
- Huazhong University of Science and Technology (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1111/bjh.19938
- Citations
- 3
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province